N-ethylamphetamine

Year(s) and type of review / ECDD meetings
Drug Class

Recommendation (from TRS)

ECDD Technical summary
This substance is a racemic mixture with an amphetamine-like pharmacological profile. It is a central nervous system stimulant and is self-administered by the rhesus monkey under experimental conditions. No data are available on the clinical abuse lability of this substance, on the nature and magnitude of public health or social problems associated with its use or abuse, or on the epidemiology of its use and abuse. The substance is legislatively controlled in several countries and there are few reports on its therapeutic usefulness. Products containing the substance are marketed in several countries and there have been only a small number of reports of illicit trafficking in the drug. On the basis of the data outlined above, it was the consensus of the Expert Committee that N-ethylamphetamine met the criteria in article 2, paragraph 4, for control under the Convention on Psychotropic Substances, and should therefore be placed in Schedule IV of the Convention.

ECDD Recommendation

Inclusion in Schedule IV of the 1971 Convention on Psychotropic Substances